Sudhakar Rao, MD
Obstetrics & Gynecology · Worcester, MANPI 1396709374
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,152 of the $1,686 with a category attached, or 68.3%. Ferring Pharmaceuticals Inc. accounts for 71.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $1,467 and has fallen 89.7% since, to $152 in 2025.
Across 13 payments — averaging $129.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$1K
- Roche Diagnostics Corporation$241
- Dilon Technologies, Inc.$152
- Astellas Pharma US Inc$30
- Biohaven Pharmaceutical Holding Company Ltd.$25
- Therapeuticsmd, Inc.$14
- plus $24 from 2 others
What the payments were for
- Consulting fees$1,15268%
- Food & beverage$53432%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 4 | $1,200 |
| Roche Diagnostics Corporation | 2 | $241 |
| Dilon Technologies, Inc. | 1 | $152 |
| Astellas Pharma US Inc | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Channel Medsystems, Inc. | 1 | $13 |
| Coopersurgical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,686 in reported general payments places this provider in the 85th percentile of 910 obstetrics & gynecology providers in Massachusetts.
See all obstetrics & gynecology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 35 | $1,309 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Worcester
- Erica RobinsonWorcester$32K
- Tara ChuteWorcester$7K
- Soheil Amin HanjaniBrockton$386K
- Joelle LiemanBrighton$215K
- Elizabeth OnyemelukweBoston$135K
- James GreenbergBoston$119K
- Stephanie AlimenaBoston$75K
- Denis VaughanBoston$38K
- Lara KingstonPlymouth$37K
- Roxanne GardnerBoston$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.